numbers are not restated by quarters with change in new accounting policy as not material. Though yearly numbers are restated. 4 The full benefit from the structural change in trading conditions is likely
continuous improvement in margin from 2Q 2017 to 1Q 2019. The Integrated PET margin improvement since March 2019 in Asia region is expected to benefit IVL globally especially from the recent weakness in PX
also expected to remain below expectation for the rest of FY 2019 due to ongoing weakness in IPA margin. The strength in the core businesses (Integrated PET, Fibers and Packaging) is likely to remain for
likely damage the intermediary or the capital market or have an impact on the national security, and that they are required to report violations or any significant abnormality to the person responsible for
policy relevant to their job function; (2) communicate to the employees and contractors that they should exercise precaution and refrain from using the organization’s information systems that may likely
remaining two segments, Integrated Oxides & Derivatives and Specialty Chemicals are expected to resume their earnings from unplanned shutdowns, except IPA which we believe will recover over the next 12-18
production and earnings including new geographies. The quarter saw a spike in raw material prices, especially for paraxylene, which is expected to normalize going forward. Nevertheless, PET margins were
meet market demand in 3Q17. Therefore, the tailwinds in volume and margins are expected to handsomely beat earnings estimates on a fully diluted basis following the exercise of W1 warrants. 3 In last
and household credit will increase. Meanwhile, competition for deposits is expected to be mild, as although the economy is likely to be on the rise, recovery remains concentrated in certain business
. Meanwhile, competition for deposits is expected to be mild, as although the economy is likely to improve, the recovery remains concentrated in certain business sectors. There is considerable excess liquidity